
Subnet Session with Michaela Bazo, CEO of Metanova: Rewiring Drug Discovery with SN68
Revenue Search: Inside Bittensor
00:00
What early metrics and milestones validate progress
Michaela highlights token launch context, milestone-based biotech validation, and early metrics: quantity, diversity, and analogs to approved drugs.
Play episode from 29:41
Transcript


